New Zealand-based health tech company ableX has pushed the button on its NZ$1.2 million (US$0.870 million) capital raising via Snowball Effect, the country’s leading private equity investment marketplace. An announcement has been expected since mid July.
Founded in 2010, ableX is a subscription-based digital healthcare solution for major neurological conditions such as stroke and dementia. It provides an interactive hardware device combined with a software-based recovery programme, which enables patients to recover more independence and care teams to be more productive. There are over 700 units in use with hospitals and outpatients across New Zealand and Australia.